Federal award
MEDPHARM INC.
HT941025P0022
Contract
Obligated and Ceiling
- Obligated (net)
- $517,464.84
- Ceiling (potential value, not spending)
- $1,455,315.95
- Current value
- $535,871.39
- Gross positive obligations
- $522,700.19
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- MEDPHARM INC. · DLM6VHZ3VUN3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- MEDPHARM INC. · DLM6VHZ3VUN3
- Awarding agency
- Department of War · sub-agency 97DH · office HT9410
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- HT941025P0022
- Award type code
- B
- Actions
- 4 · Dec 13, 2024 to Apr 23, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 23, 2026 | FY2026 | P00003 | B | −$5,235.35 | — |
| Jan 7, 2026 | FY2026 | P00002 | C | $284,789.93 | — |
| Jun 30, 2025 | FY2025 | P00001 | B | $0.00 | — |
| Dec 13, 2024 | FY2025 | 0 | — | $237,910.26 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.